Mumbai, Feb. 21:

Life-sciences company Avesthagen Ltd has launched seven botanical bioactives under the Avesta brandname targeting specific conditions like diabetes, bone-loss and cardiovascular-diseases.

For starters, the branded bio-active ingredients will be used in food-products, even as human trials are underway to launch the ingredients as prescription, pharmaceutical products a year later, said Dr Villoo Morawala Patell, Chairperson and Managing Director of Avesthagen.

The bioactives, manufactured at the company’s plant near Bangalore, will be sold through the fast-moving consumer goods channel, and the pharmacy channel, said Mr Samaresh Parida, Avesthagen’s Chief Operating Officer.

Contd on page 2......